Associate Director/Associate Chief, Division of Cardiovascular Medicine; Professor, Internal Medicine, Ohio State University Wexner Medical Center; Director, Cardio-Oncology Program; Editor, E-Learning, www.acc.org; CME Editor JACC; Editor-in-Chief, T
Cardiology
Dr. Ragavendra Baliga, MD
|
|
Give Review
Ragavendra Baliga practices Cardiology. He graduated from University of Michigan, Ann Arbor. University of Michigan, Ann Arbor is a one of the best medicals schools. University of Michigan, Ann Arbor is ranked 10 in research and 5 in primary care medicine He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACC)". Ragavendra Baliga has written publications. He has 57 publications published with PubMed. The lastest paper is: 'Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature my...' He accepts all Medicare patients.
Publications
- Venous thromboembolism in cancer patients: a review of risk assessment, prevention and management.
- Population Study of Urban, Rural, and Semiurban Regions for the Detection of Endovascular Disease and Prevalence of Risk Factors and Holistic Intervention Study (PURSE...
- Practice guidelines for the diagnosis and management of systolic Heart failure in low- and middle-income countries.
- From clinical observation to mechanism--Heyde's Syndrome.
- Protecting a billion Hearts.
- Management of STEMI in low- and middle-income countries.
- Echocardiography and Heart Failure: A Glimpse of the Right Heart.
- The Role of Imaging in Aortic Dissection and Related Syndromes.
- Growth hormone replacement delays the progression of chronic Heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-bli...
- Primary prevention of cancer-related Thrombosis: Special focus on ambulatory patients.
- Cardiovascular abnormalities in Klinefelter Syndrome.
- beta-blockers in Heart failure: breaking tradition to avoid diabetes?
- Treatment of Heart failure in pulmonary arterial hypertension--the urgency of getting this right.
- Reducing the burden of stage B Heart failure and the global pandemic of cardiovascular disease: time to go to war with the "barefoot" troops!
- HDL-cholesterol: perfection is the enemy of good?
- Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic Heart failure (the...
- Reactive oxygen species mediate amplitude-dependent hypertrophic and apoptotic responses to mechanical stretch in cardiac myocytes.
- NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
- Abdominal obesity, impaired nonesterified fatty acid suppression, and insulin-mediated glucose disposal are early metabolic abnormalities in families with premature my...
- Regional myocardial blood flow redistribution as a cause of postprandial Angina pectoris.
- Effects of components of meals (carbohydrate, fat, protein) in causing postprandial exertional Angina pectoris.
- Safety and efficacy of atorvastatin in Heart transplant recipients.
- Pharmacogenomics of congestive Heart failure.
- Spironolactone treatment and clinical outcomes in patients with systolic dysfunction and mild Heart failure symptoms: a retrospective analysis.
- Never too late to drink from the fountain of youth.
- Applying hypertension guidelines to reduce the burden of Heart failure.
- Energizing diastole.
- Statins or status quo?
- Editorial: the concertina pump.
- "Stiff central arteries" syndrome: does a weak Heart really stiff the kidney?
- The race to tissue oxygenation: special teams GoGoGo.
- Editorial: Bench to bedside to home: homing-in on therapy that begins at home.
- Hemodynamic monitoring in the diagnosis and management of Heart failure. Preface.
- Using a magnet to strike gold.
- Editorial: Do biomarkers deserve high marks?
- Salt never calls itself sweet.
- Medical therapy for rheumatic Heart disease: is it time to be proactive rather than reactive?
- Pharmacogenomics transforming medicine to create a world of immortal Struldbruggs or even a Methuselah? So be it!
- Adrenergic excess, hNET1 down-regulation, and compromised mIBG uptake in Heart failure poverty in the presence of plenty.
- Editorial. Unleashing our healthy avatars using cardiovascular genetics.
- Staying in the pink of health for patients with cardiorenal anemia requires a multidisciplinary approach.
- Editorial: Giant strides and baby steps in pediatric cardiac disease and Heart failure in children.
- Editorial: depression in Heart failure is double trouble: warding off the blues requires early screening.
- Editorial: Sudden death in Heart failure: an ounce of prediction is worth a pound of prevention.
- Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure: Nesiritide Redux.
- Early detection and monitoring of vulnerable myocardium in patients receiving chemotherapy: is it time to change tracks?
- Clinical trials to "real-world" Heart failure: applying risk stratification to deliver personalized care.
- Reducing the burden of stage B Heart failure will require connecting the dots between "knowns" and "known unknowns".
- The MIBG tarot: is it possible to predict the efficacy of beta-blockers in congestive Heart failure?
- Apoptosis in Myocardial ischemia, infarction, and altered Myocardial states.
- Cardiac and skeletal muscle insulin resistance in patients with coronary Heart disease. A study with positron emission tomography.
- What's in a name? Would that which we call death by any other name be less tragic?
- When it is inflamed, it hurts.
- Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes.
- Cardiovascular and hormonal responses to food ingestion in humans with spinal cord transection.
- Increased susceptibility to development of triggered activity in myocytes from mice with targeted disruption of endothelial nitric oxide synthase.
Schools
St John39s Medical College Rajiv Gandhi University Of Health Sciences
Boston Med Center
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Acute Venous Embolism Thrombosis
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACC)
Education
-
University of Michigan, Ann Arbor -
University of Texas Southwestern Medical School -
Boston University Medical Center -
Brigham and Women's Hospital -
Harvard Medical School -
St. John's Medical College
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1790722197 | |
| NPPES Provider LastName | BALIGA | |
| NPPES Provider FirstName | RAGAVENDRA | |
| NPPES Provider ZIPCode | 432101240 | |
| NPPES Provider State | OH | |
| Specialty Description | Cardiology | |
| Total Claim Count | 486.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1790722197 |
| Last Name Of The Provider | BALIGA |
| First Name Of The Provider | RAGAVENDRA |
| View All |
Similar Doctors
|
Dr. Arnold P. Good, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Feliciano R. Dolor, MD |
|
Dr. Vincent J. Pompili, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vipin B. Koshal, DO
This Doctor is OpenDoctor Recommended.
|
|
Dr. Karanvir S. Grewal, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Imtiaz Ahmed, MD |
|
|
Dr. Virenkumar M. Patel, MD |
|
|
Dr. Montoya K. Taylor, MD
This Doctor is OpenDoctor Recommended.
|